Related Experiment Videos
Nebulised ipratropium and salbutamol in asthma
Archives of Disease in Childhood
|June 1, 1986
Insights
Nebulized salbutamol alone or combined with ipratropium showed similar hospital stays for children with asthma. However, salbutamol alone was more effective for severe asthma, while the combination worked better for mild asthma.
Area of Science:
- Pediatric Pulmonology
- Pharmacology
Background:
- Asthma is a common chronic respiratory disease in children.
- Bronchodilators like salbutamol and ipratropium are frequently used to manage pediatric asthma exacerbations.
Purpose of the Study:
- To compare the efficacy of nebulized salbutamol versus a combination of salbutamol and ipratropium in children with asthma.
- To evaluate treatment response based on asthma severity.
Main Methods:
- A study involving 138 children treated with either nebulized salbutamol or a combination of salbutamol and ipratropium.
- Assessment of length of hospital stay and number of nebulized doses required.
Main Results:
- No significant difference in hospital stay or nebulized doses between the two treatment groups.
- Salbutamol alone demonstrated a greater response in children with severe asthma.
- Combined treatment showed a better response in children with mild asthma.
Conclusions:
- The choice of bronchodilator in pediatric asthma may depend on disease severity.
- Combined salbutamol and ipratropium may be more beneficial for mild asthma cases.
- Further research could explore optimal treatment strategies for different asthma severities in children.
Abstract:
Treatment with nebulised salbutamol or a mixture of salbutamol and ipratropium was given to 138 children. Length of hospital stay and number of nebulised doses required did not differ. In severe asthma response was greater with salbutamol alone. In mild asthma response was greater with combined treatment.